key: cord-0030186-r47vyul7 authors: Shmeleva, Evgeniya V.; Gomez de Agüero, Mercedes; Wagner, Josef; Enright, Anton J.; Macpherson, Andrew J.; Ferguson, Brian J.; Smith, Geoffrey L. title: Smallpox vaccination induces a substantial increase in commensal skin bacteria that promote pathology and influence the host response date: 2022-04-21 journal: PLoS Pathog DOI: 10.1371/journal.ppat.1009854 sha: 358bbdbfd48eb4e26662eb0aaadacce7d3ddfd69 doc_id: 30186 cord_uid: r47vyul7 Interactions between pathogens, host microbiota and the immune system influence many physiological and pathological processes. In the 20(th) century, widespread dermal vaccination with vaccinia virus (VACV) led to the eradication of smallpox but how VACV interacts with the microbiota and whether this influences the efficacy of vaccination are largely unknown. Here we report that intradermal vaccination with VACV induces a large increase in the number of commensal bacteria in infected tissue, which enhance recruitment of inflammatory cells, promote tissue damage and influence the host response. Treatment of vaccinated specific-pathogen-free (SPF) mice with antibiotic, or infection of genetically-matched germ-free (GF) animals caused smaller lesions without alteration in virus titre. Tissue damage correlated with enhanced neutrophil and T cell infiltration and levels of pro-inflammatory tissue cytokines and chemokines. One month after vaccination, GF and both groups of SPF mice had equal numbers of VACV-specific CD8(+) T cells and were protected from disease induced by VACV challenge, despite lower levels of VACV-neutralising antibodies observed in GF animals. Thus, skin microbiota may provide an adjuvant-like stimulus during vaccination with VACV and influence the host response to vaccination. Interactions between pathogens, host microbiota and the immune system influence many physiological and pathological processes. In the 20 th century, widespread dermal vaccination with vaccinia virus (VACV) led to the eradication of smallpox but how VACV interacts with the microbiota and whether this influences the efficacy of vaccination are largely unknown. Here we report that intradermal vaccination with VACV induces a large increase in the number of commensal bacteria in infected tissue, which enhance recruitment of inflammatory cells, promote tissue damage and influence the host response. Treatment of vaccinated specific-pathogen-free (SPF) mice with antibiotic, or infection of geneticallymatched germ-free (GF) animals caused smaller lesions without alteration in virus titre. Tissue damage correlated with enhanced neutrophil and T cell infiltration and levels of proinflammatory tissue cytokines and chemokines. One month after vaccination, GF and both groups of SPF mice had equal numbers of VACV-specific CD8 + T cells and were protected from disease induced by VACV challenge, despite lower levels of VACV-neutralising antibodies observed in GF animals. Thus, skin microbiota may provide an adjuvant-like stimulus during vaccination with VACV and influence the host response to vaccination. Smallpox was caused by variola virus and was eradicated by widespread dermal vaccination with vaccinia virus (VACV), a related orthopoxvirus of unknown origin. Eradication was declared in 1980 without an understanding of the immunological correlates of protection, or knowledge of the effect of smallpox vaccination on the local microbiota. Here we Vaccinia virus (VACV) is the live vaccine that was used to eradicate smallpox, a disease caused by the related orthopoxvirus, variola virus, and declared eradicated by the World Health Organisation in 1980 [1] . During the smallpox eradication campaign, early vaccine batches were grown on the flanks of animals and, consequently, were not bacteriologically sterile. Vaccination was achieved by multiple skin puncture using a bifurcated needed containing a drop of vaccine suspended between the two prongs of the needle. Therefore, both the vaccine and the method of vaccination may have introduced bacteria into the vaccination site. Following vaccination a local lesion developed that healed in 2-3 weeks and left a characteristic vaccination scar. A careful study of smallpox vaccination outcomes in the USA described several serious dermal or neurological complications of vaccination [2] , although bacterial infection of the vaccination site was not highlighted. Vaccination induced long-lasting humoral and cellular responses, although the precise immunological correlates of protection remain uncertain [3] . VACV encodes scores of proteins that block the innate immune response and induce local immunosuppression [4] and manipulation of these proteins can affect virulence and adaptive immunity [5] . Secondary bacterial infection is sometimes a consequence of viral infection; classic examples are bacterial pneumonia following influenza virus, respiratory syncytial virus or parainfluenza virus infection [6] . These bacterial infections may be promoted by virus-induced tissue damage facilitating bacterial entry into tissue, loss of anti-microbial proteins, or virus-induced immunosuppression enabling invasion by commensal organisms. Bacteria causing these secondary infections are often derived from the host microbiota [7, 8] . Bacterial infection has been described following infection by several poxviruses including avipoxvirus [9] , cowpoxvirus [10] , monkeypox virus [11] and variola virus [12] although this was not highlighted as a complication of smallpox vaccination [2] . Vaccine development can be a slow and expensive process and understanding how to deliver antigens optimally to induce strong adaptive immunity remains poor. In particular, understanding how innate immunity leads to development of adaptive immunity is incomplete [13, 14] . The activation of dendritic cells by innate immunity enhances antigen presentation and thereby improves the adaptive memory response [15] , but innate immunity may also cause swift elimination of antigens, and so diminish adaptive immunity [16] . Since bacterial components are sometimes used as adjuvants to enhance innate immunity and vaccine efficacy [17] , studying the role of microbiota following vaccination is important. In this study, the mouse intradermal model of VACV infection [18] was used to make a detailed investigation of the recruitment of inflammatory cells into the infected tissue. Previously, the cellular infiltrate in this model was found to contain abundant neutrophils and T cells and was markedly different to the response to respiratory infection [19] . Neutrophil recruitment is a hallmark of bacterial infection [20] and this led to the discovery here that the local skin microbiota expanded greatly following dermal VACV infection. Data from vaccinated antibiotic-treated or germ free (GF) mice showed that the pathology at the site of the viral infection is dominated by commensal bacteria, without influencing virus replication. Notably, the depletion of bacteria resulted in an alteration to the cellular infiltration into infected tissue and this might affect the subsequent adaptive immune response. This study highlights a role for commensal bacteria in enhancing the immune response following dermal vaccination and has implication for other vaccines based upon infectious poxviruses or other viral vectors that are delivered by dermal vaccination. Intradermal (i.d.) infection of the mouse ear pinnae with VACV strain Western Reserve (WR) results in the development of a skin lesion at the site of infection that mimics smallpox vaccination in man. A lesion appears at d 6 post infection (p.i.), increases gradually to about d 10 and resolves by d 21 [18] . The model has been used to study the contribution of individual VACV proteins to virulence and immunogenicity [21, 22] . Here the local innate and cellular immune responses to i.d. vaccination with VACV were characterised in detail, including quantifying subpopulations of infiltrating myeloid cells throughout infection. Flow cytometry showed a substantial increase in CD45 + CD3 -CD5 -CD19 -NK1.1 -CD11c -Siglec-F -Ly6G + cells (neutrophils) in ear tissue at all times p.i. (Fig 1A and 1B) . Along with the surface markers, the morphological characteristics of this population (spherical~8-10 μm cells with highly segmented nuclei) confirmed their identity as neutrophils (S1 Fig) [23] . The number of neutrophils increased up to 10 d p.i., and by d 5 had increased~130 fold compared to mock-infected tissue (Fig 1B) , coinciding with the first appearance of a dermal lesion. Neutrophils are part of the innate immune system and are front-line effector cells for defense against bacterial infection [20] . Their abundance in VACVinfected tissue suggested that bacterial co-infection might be present. To investigate if there is an expansion of bacteria after i.d. infection with VACV, bacterial colony-forming units (CFUs) in infected tissue were quantified. CFUs in VACV-infected tissue was at least 100-fold greater than mock-infected tissue at all time points (Fig 1C) and at the peak at 10 d p.i. was about 1000-fold greater than control (Fig 1D) . Given that the virus inoculum was bacteriologically sterile, these results suggest increased growth of commensal bacteria after VACV infection, possibly due to local virus-induced immunosuppression. Furthermore, as not all bacteria can grow under the experimental conditions (oxygenated blood agar) used in our experiments, the bacterial presence is likely to be underestimated and so larger than demonstrated in our study. Notably, the time of maximum number of bacteria and neutrophils correlated with maximum lesion size, suggesting a link between skin microbiota and the severity of pathology. To investigate the identity of the bacteria present during infection and to compare this with the microbiome in uninfected skin, 16S ribosomal RNA gene (rRNA) sequencing was performed. So that bacteria from the skin surface and within lesions was included, total genomic DNA was extracted directly from whole VACV-infected and non-infected ear tissues and next generation sequencing of the amplified V4 region of bacterial 16S rRNA was performed. Sequencing was carried out from material extracted directly from infected tissues without prior culturing to avoid bias introduced by the culturability of bacteria that might be present. Almost all the bacterial families found belonged to: These are consistent with mouse skin microbiota reported previously [24, 25] , suggesting that the source of the enhanced numbers of bacteria in VACVinfected tissue is the skin rather than environment. Analysis of bacterial sequences at the family, genus and species levels showed significant changes in the composition of skin microbiota following infection with VACV (Fig 2, S2 and S3 Figs). Although mock-infection itself resulted in moderate modification of skin microbiome, the most significant changes occurred at d 5, 8 and 12 p.i., especially d 8 and 12, which was clearly demonstrated by principal component analysis (Fig 2A, S2B and S3A Figs) as well as multivariate beta diversity analysis (S1 Table) . The relative abundance of some dominant genera in intact skin such as Sporosarcina and Staphylococcus decreased at late times post VACV infection, while the proportion of Streptococcus, Enhydrobacter and Corynebacterium increased ( Fig 2B) . Perturbation of skin microbiome also occurred within the same genus, for instance VACV infection resulted in a rise of relative abundance of Staphylococcus aureus, a well-known opportunist, over other species of Staphylococcus (S3B Fig) . While averaged data visualised as stack plots cannot represent in full the observed microbiota shift, heatmaps ( Fig 2C, S2A and S3C Figs) illustrate that the majority of d 8 and 12 VACV-infected samples had very pronounced dominance of~1-3 bacterial genera, which differs from normal microbiota. However, specific dominant taxa varied from sample to sample. Therefore, there is no particular type of bacterium that spread favourably after VACV infection. Instead, random different bacteria are increased in infected samples. Thus, VACV infection leads to changes in the skin microbiome and the expansion of opportunistic bacteria. To investigate the influence of skin microbiota on lesion formation, a broad-spectrum bactericidal antibiotic (AB, ceftriaxone) was administered intraperitoneally (i.p.) over 13 d after VACV infection to suppress bacterial growth. C57BL/6 specific-pathogen-free (SPF) mice were infected i.d. with VACV, and one group received antibiotic treatment (SPF, AB-group), while another received phosphate-buffered saline (SPF, NoAB-group). Antibiotic treatment caused a significant reduction in lesion size after infection with VACV strain WR, a widely used laboratory strain of VACV ( Fig 3A) . A similar observation was made following infection with VACV strain Lister, a strain used widely for smallpox vaccination in humans (S4 Fig). To confirm that this effect was due to the presence of bacteria, rather than a non-specific consequence of antibiotic treatment, genetically-matched germ-free (GF) mice were infected i.d. with VACV strain WR. These mice showed delayed lesion formation and had a three-fold reduction in lesion size compared to SPF animals ( Fig 3B) . Topical administration of antibiotic creams on the infected ears also resulted in a reduction of lesion size following VACV infection (S5 Fig) . However, it was not possible to control the dose administered because the animals tend to groom themselves and each other, leading to ingestion of the applied creams. Antibiotic treatment can influence antiviral immunity when administered orally [26] and so to minimise the influence on gut microbiota, the antibiotic was administered i.p. for all our experiments. To avoid changes in microbiota prior to infection, antibiotic treatment was only started from d 1 p.i. Throughout ceftriaxone treatment, the health status of animals and their leukocyte composition in peripheral blood, spleen and bone marrow were unaltered (S6 Fig) . Smallpox vaccination increases skin bacteria that promote pathology and influence the host response Next the virus titres in infected tissue with or without antibiotic treatment were determined. Notably, despite considerable differences in lesion size, the viral titres in infected ear tissues were unaltered ( Fig 3C) . Seeding of the ear tissues obtained from AB-animals on blood agar plates did not result in bacterial growth, which might be explained by the presence of antibiotic in the tissue extracts that prevent bacterial growth, rather than by the total absence of bacteria from infected lesion. This indicated that: i) antibiotic treatment has no impact on virus replication, and ii) lesion size was influenced by the presence of bacteria rather than virus titre. Histological examination of infected lesions showed that VACV-infected ear tissue from SPF mice contained significant cellular infiltrate and general signs of inflammation throughout the tissue as well as regions of necrosis at day 8 p.i. (Fig 4A) . At day 12 p.i. the majority of the ear tissue in the NoAB-group of animals was necrotic whereas there was substantially less necrosis and tissue damage in the AB-group (Fig 4A) . A striking difference in histological changes after VACV infection was observed when comparing GF and SPF mice. Infected ears of the GF animals had significantly reduced cell infiltration and only very mild tissue necrosis compared with infected ears from SFP mice ( Fig 4B) . Collectively, these observations indicate that skin microbiota promote lesion development after VACV infection and the smaller lesion sizes and lack of pathological tissue changes in GF and antibiotic-treated groups were due to the absence of microbiota or antibiotic-induced suppression of bacterial expansion. Smallpox vaccination increases skin bacteria that promote pathology and influence the host response Next, we compared the local immune response to VACV infection in ear tissue of antibiotictreated and untreated SPF animals. Recruitment of immune cells was low on d 1-4 p.i. ( Fig 5A) but there was a sharp increase of Ly6C + inflammatory monocytes on d 5, followed by large leukocyte infiltration at d 7. Notably, the antibiotic-treated group showed a substantial reduction in the recruitment of multiple subpopulations of myeloid and lymphoid cells at d 7 p.i. (Fig 5A) . By d 12 p.i., several subpopulations of leukocytes had declined, except for neutrophils in the NoAB-group, which continued to increase. During infection there was a notable positive correlation between the lesion size and the numbers of infiltrating neutrophils or TCRαβ T cells and this correlation did not hold for any other cell type ( Fig 5B) . To analyse the local inflammatory environment further, we measured an array of cytokines and chemokines in the ear tissue at d 5, 8 and 12 p.i. in control and antibiotic-treated mice. Smallpox vaccination increases skin bacteria that promote pathology and influence the host response Consistent with the smaller lesions and reduction in cellular infiltration, among 17 different inflammatory mediators measured, there were reductions of IFNɣ, TNFα, CCL2, CCL4, CCL7, CXCL1 and CXCL10 levels in the antibiotic-treated group compared to controls at d 8, and also in the amount of CCL4 and CCL7 at d 12 p.i. (Fig 6A) . Similar differences were also Smallpox vaccination increases skin bacteria that promote pathology and influence the host response evident when comparing infected GF mice with SPF mice. Levels of IFNɣ, TNFα, CCL2, CCL7, CXCL1 and CXCL10 were considerably diminished in the GF mice ( Fig 6B) . These data indicate that the presence of skin microbiota accelerates overall immune cell recruitment and cytokine/chemokine production in VACV-infected skin. To assess the role of microbiota in the generation of VACV-specific adaptive immunity, we measured VACV-specific CD8 + T cell numbers and anti-VACV neutralising antibodies in samples obtained from SPF groups, with or without antibiotic treatment, and GF mice one month after vaccination. Absolute numbers of splenic CD4 + and CD8 + T cells, as well as VACV-specific CD8 + cells, were similar in all three groups of animals (Fig 7A and 7B, and S7 Fig) . Also, neither absolute numbers of splenocytes, all CD45 + , nor CD45 + non-T cells differed significantly in vaccinated SPF and GF mice (S8 Fig). However, the levels of VACV neutralising antibodies were 3-fold lower in GF animals than in either group of SPF animals (Fig 7C) . Despite the reduced antibody response in the vaccinated GF mice, all groups showed protection from disease upon intranasal challenge with a lethal dose of VACV (Fig 7D-7F ). Each SPF group showed a small (~10%) transient weight loss after challenge before recovery. These data indicate that the GF mice may have an impaired capacity to generate neutralising Smallpox vaccination increases skin bacteria that promote pathology and influence the host response Smallpox vaccination increases skin bacteria that promote pathology and influence the host response antibody following i.d. vaccination with VACV, but that this does not affect their capacity to develop protective immunity against re-challenge in this model. These data do not distinguish between the deficiency of antibody-dependent immunity in GF animals per se and the decline in humoral immune responses due to a lack of stimulatory signals from microbiota. We attempted to address this by comparing vaccination of GF and S. aureus gnotobiotic mice, which were generated by mono-colonisation of GF animals with S. aureus strain NCTC 8325 two weeks prior to the i.d. vaccination with VACV. Unfortunately, mice reconstituted with S. aureus, differed from GF controls with lower body mass and reduced subcutaneous and visceral fat, possibly suggesting ongoing inflammation after colonisation with S. aureus. For these reasons, S. aureus colonised animals proved unsuitable for comparison. Host microbiota influence many physiological and pathological processes throughout life, including pre-and postnatal development, aging, metabolism and immunity [27, 28] . Commensal organisms play an important role in the defense against pathogens, not only by preventing microorganisms from colonising epithelial niches, but also by influencing homeostasis, maturation and regulation of the immune system [24, 29] . During infection by bacteria or viruses, host microbiota may either promote or diminish pathology [30, 31] and the ability of commensals to influence inflammation via regulation of innate immune responses suggests that microbiota could be manipulated for host health benefit [24, 29, 32] . This study reports a 1000-fold increase in local skin microbiota after i.d. vaccination with VACV (Fig 1) . This expanded bacterial load dominates the development of skin lesions following vaccination (Fig 3 and S5 Fig) and enhances the innate immune response by increasing leukocyte infiltration and local cytokine/chemokine (Figs 5 and 6) . Notably, the formation of the antigen-specific CD8 + T cell response was found to be microbiota independent (Fig 7) . Antibody-mediated immunity, on the other hand, was reduced 3-fold in GF animals (Fig 7) , although further investigation is needed to determine the degree to which this observation is microbiota-dependent. Multiple factors provide skin barrier function and control microorganisms on the skin surface including acidic pH, high-salt, antimicrobial proteins (defensins, cathelicidins, peptidoglycan recognition proteins, ribonucleases and psoriasin), free fatty acids, ceramide and filaggrin [8, 33, 34] . Keratinocytes and sebaceous glands, which synthesise these substances [35, 36] , are highly susceptible to VACV infection [37] . VACV-induced shut-off of host protein synthesis in infected cells [38] may diminish production of antimicrobial substances and therefore induce changes in local microbiota. Here, VACV infection is shown to induce large changes in skin microbiota, especially later after infection (Fig 2, S2 and S3 Figs) , with changing dominance of different bacterial taxa. These dominant taxa varied between infected animals, indicating colonisation by random opportunistic bacteria, a common feature for secondary bacterial infections [39] . The ability of bacterial commensals to rapidly expand has been demonstrated previously; for instance, the doubling time of S. aureus in human nasal cavity is 2-4 h [40] , which suggests a bacterial increase of 60-2000-fold in 24 h is possible (not accounting for bacterial death and assuming sufficient nutrient availability). The bacterial growth rate in a host organism depends on multiple factors including immune status of the host. During experimental sepsis the speed of bacterial expansion can be more than 100-fold per 24 h, when the immune system loses control of the infection [41] . Here we observed up to 100-fold increase of bacterial presence within the first 24 h post VACV-infection (Fig 1C and 1D) , which can be explained by the fact that Smallpox vaccination increases skin bacteria that promote pathology and influence the host response VACV is a very potent suppressor of the local innate immune response [5] . Further bacterial expansion over two weeks post i.d. VACV infection was only 10-fold (Fig 1C and 1D ) possibly slowing down due to nutrient limitations and, after 5 dpi, the activation of the immune system and leukocyte infiltration (Figs 5 and 6) , which limits bacterial growth and increases their death. Although increased bacterial, but not viral, load correlated with enhanced lesion size, these increased bacteria were not sufficient for lesion formation, because bacteria increased 1-5 d p. i., before lesions appeared on d 6 (Figs 1C, 1D, 3A and 3B) . Furthermore, GF mice still developed lesions, although these were delayed and diminished (Fig 3B) . Inflammation was also reduced in GF animals following dermal scarification of VACV into the mouse tail [42] . VACV infection may disrupt skin integrity due to VACV-induced cytopathic effect [43] or cell motility [44] that enabled bacteria to enter tissue and proliferate. Local immunosuppression induced by VACV proteins that block innate immunity [4, 5] including production of glucocorticoids by a VACV-encoded steroid biosynthetic enzyme [45, 46] might facilitate further bacterial growth. Notably, a VACV strain lacking this enzyme induced smaller dermal lesions [22] . In the future, it would be interesting to measure microbiota after infection by this and other VACV mutants lacking specific immunomodulators, because the lesion sizes depend on the VACV strain used for infection [22] , and are influenced by viral immunomodulatory proteins, without any direct impact on viral replication. These observations with VACV have similarity to those made with the trypanosome Leishmania major in which skin lesions were smaller in GF mice than SPF mice [24] . That study also demonstrated the importance of the skin resident immune system in the progression of inflammation [24] . Inflammation after exposure to pathogens can be caused and/or aggravated by opportunistic commensals [25] . Bacterial invasion provides potent activators of innate immunity that promote cytokine/chemokine production and immune cell recruitment [47] . Consistent with this, larger lesions were associated with more neutrophils and T cells (Fig 5B) , and increased tissue cytokines and chemokines (Fig 6) . Interestingly, depletion of Ly6G + cells results in delayed lesion healing post epicutaneous infection with VACV [37] , consistent with the involvement of neutrophils in bacterial clearance and the resolution of inflammation. However, whether bacterial infection per se [48] or immune system activation by bacteria [49] induce tissue damage is unknown. During SARS-CoV-2 infection, increased neutrophil counts correlate with severe pathology and hyper-inflammation. Specifically, neutrophils are elevated in the second week from the onset of symptoms and are higher in severe COVID-19 in comparison with moderate disease [50] [51] [52] [53] . Similarly, the presence of neutrophils predisposes to enhanced respiratory syncytial virus infection [54] . In our study, the massive recruitment of immune cells in infected tissue coincided with the appearance of the skin lesion. 16S rRNA gene sequencing did not reveal an expansion of a particular bacterial taxa, suggesting that the enhancement of the innate immune response does not seem to be associated with specific bacteria; rather, various types of bacteria are able to spread in the lesions (Fig 2C, S2A and S3C Figs) and induce inflammation. Therefore, three factors may influence lesion development after i.d. vaccination with VACV: 1) virus-induced tissue damage, 2) tissue destruction by invading bacteria, and 3) immunopathology. Lesion size in this i.d. model is also influenced by the age and strain of mice, and strain of VACV [22] . Bacterial lipopolysaccharides, flagellin, DNA and toxins are used as adjuvants to stimulate innate immunity and vaccine immunogenicity, mainly via enhanced antibody production [17] . Consistent with that, the innate immune response to vaccination of GF mice was lower than for genetically-matched SFP animals (Fig 6B) , and whereas VACV-specific CD8 + T cell memory did not depend on microbiota, the humoral immune response was impaired in GF mice compared with SPF animals (Fig 7A-7C) . However, necessarily experiments on GF mice Smallpox vaccination increases skin bacteria that promote pathology and influence the host response and SPF mice were performed in separate animal facilities, which might influence the observed differences in VACV-neutralising antibodies. Nonetheless, no reduction of anti-VACV antibodies in antibiotic-treated SPF animals was seen (Fig 7C) , despite reduced cytokine/chemokine levels. This maybe because antibiotic treatment does not eliminate bacteria, but limits their growth and spread, and therefore, bacteria and bacterial pathogen-associated molecular patterns (PAMPs) are still present at lower levels. These might be sufficient to provide the adjuvant-like stimulus required for a robust adaptive immune response. Others also reported reduced antibody responses in both GF and antibiotic-treated animals [55, 56] . However, these studies used animals pretreated with antibiotic per os to induce alterations in the gut microbiome, while we administrated antibiotics i.p. only from 1 d after infection by VACV. Previous studies suggested that the influence of microbiota on T-cell memory may depend on the inoculation route or pathogen [55] . The influence of host microbiota on vaccination efficacy is a relatively new area of investigation and differing results have been reported [57] [58] [59] [60] . Indeed, vaccine immunogenicity is influenced by multiple factors, such as age, genetics, previous exposures to various pathogens, assessment of distant or local microbiota, route of vaccination and the type of vaccine, making the design of experiments and interpretation of results challenging. Notably, in our study, the induction of CD8 + T cell memory following i.d. vaccination with VACV is microbiota-independent and not perturbed by the presence of bacteria in the skin, gut or elsewhere (Fig 7) . Although VACV-specific memory CD8 + T cells may have functional differences in the absence of microbiota [61] , and despite reduced titres of VACV-specific neutralising antibodies, GF animals were protected as well as SPF mice from i.n. challenge with VACV one month ( Fig 7D-7F ). SPF mice that had been treated with antibiotic were also protected as well as control mice at 3 months after vaccination (S9 Fig). This reflects the solid immunity induced by vaccination in all groups and consequential resistance to challenge with a high dose of VACV. These conditions might not be suitable to reveal subtle differences in protection between the groups used, because the vaccination in our study may have resulted in the humoral or/and cellular adaptive immune response reaching a threshold, leading to full protection against challenge. Lower immunising doses or longer duration between vaccination and challenge might show differences. Nonetheless, this study illustrates the possible influence of skin microbiota for the generation of anti-VACV antibodies and this observation is important for vaccine development, as intradermal vaccination with other live vaccines might induce local expansion and changes in the composition of microbiota, and therefore, may influence the efficacy of vaccination. In conclusion, this study demonstrates that i.d. vaccination with VACV induces substantial local bacterial infection derived from skin microbiota, which function as adjuvant to increase the innate immune response leading to greater skin inflammation. The enhanced bacteria induced formation of larger dermal lesions either by direct bacterial-induced cytotoxicity or immunopathology. Vaccination with VACV generates robust long lasting immune responses that eradicated smallpox from man [1] and can protect mice from lethal challenge [21, 60] . As shown here, such protective immunity does not require additional stimuli from microbiota or other adjuvants. However, further activation of the innate immune system provided by skin microbiota might have a beneficial effect on the immunogenicity of other vaccines. Animal experiments in the UK were conducted according to the Animals (Scientific Procedures) Act 1986 under PPL 70/8524 issued by the UK Home Office. Experiments involving GF animals were performed in accordance with Swiss Federal and Cantonal regulations. Smallpox vaccination increases skin bacteria that promote pathology and influence the host response Animals and study design C57BL/6 female mice were used in all experiments of this study. Specific pathogen free (SPF) animals were purchased from Charles River and housed under SPF conditions in the Cambridge University Biomedical Services facility. Germ-free (GF) C57BL/6 mice were bred and kept at the University of Bern GF animal facility. All GF mice were confirmed to be microbialfree during breeding and during experiments using culture dependent and independent strategies. SPF mice (7 weeks old) or GF mice (7-9-weeks old) were injected intradermally (i.d.) with 10 4 plaque-forming units (PFU) of VACV strain Western Reserve (WR) or strain Lister or diluent (0.01% BSA/PBS, mock-control) into both ear pinnae. VACV used for infections was purified from infected cells in sterile conditions by sedimentation through a 36% (w/v) sucrose cushion and subsequently through a 15-40% (w/v) sucrose density gradient. When plated onto sheep blood agar these VACV preparations induced no bacterial growth. VACV titres were measured by plaque assay on BSC-1 cells and stored at -70˚C. The diluted VACV samples used for injections were titrated to confirm the accuracy of the injected dose. Some groups of animals were injected intraperitoneally (i.p.) with antibiotic or PBS for up to 13 d starting 1 d after i.d. infection with VACV. Ceftriaxone (Rocephin; Roche, Basel, Switzerland), a third-generation cephalosporin antibiotic with a broad spectrum antibacterial activity, was given at 10 mg / mouse / d. The size of lesions formed after i.d. injection of VACV into the ear pinnae were measured daily with a digital calliper. Whole ear pinnae tissues were collected before and at several times after infection. and spleens and serum samples were obtained one month p.i. to quantify T cell subpopulations and VACV neutralising antibodies. Vaccinated mice and naïve controls were challenged i.n. with 3 × 10 6 PFU of VACV WR 1 month post vaccination. The body weight of animals was measured daily. The composition of immune cells in VACV-infected ear tissues was determined by FACS as described [62] . Dead cells were excluded by addition of Zombie Fixable Viability dye (S2 Table) for 20 min followed by washing. After pre-incubation of samples with purified rat antimouse CD16/CD32 antibody (Mouse BD Fc Block) (BD Biosciences, Cat. # 553141, Franklin Lakes, New Jersey), monoclonal antibodies (mAbs) were added to the cell suspension (S2 Table) . The following mAbs were included in the myeloid panel: anti-CD45, Siglec-F, CD11c, CD11b, Ly6C, Ly6G, as well as dump channel markers (CD3, CD5, CD19, NK1.1). The lymphoid panel included CD45, NK1.1, CD3, TCRɣδ, CD4, CD8 markers. After final washing steps, cells were resuspended in PBS containing 4% paraformaldehyde (PFA) and were analysed on a BD LSRFortessa (BD Biosciences). Gating strategies are shown in S10 and S11 Figs. FACS analysis were completed using BD FACS Diva (BD Biosciences) and FlowJo (FlowJo, LLC BD, Ashland, Oregon) software. Splenocyte isolation and staining for FACS analysis were performed as described [62] . Subpopulations of splenic T cells were determined by staining with mAbs to CD45, CD3, CD8, CD4, CD62L, CD44 and MHC dextramer H-2Kb/TSYKFESV (S2 Table) . Gating strategy is shown in S12 Fig. Whole ear pinnae were homogenised in 1.5 ml flat-bottom tubes containing 400 μl of 0.01% BSA/PBS with an OMNI Tissue Homogeniser with plastic hard-tissue probes (OMNI International, Kennesaw, GA, Georgia). The homogenate was then centrifuged at 10,000 rcf for 20 Smallpox vaccination increases skin bacteria that promote pathology and influence the host response min at 4˚C and the supernatant was collected and stored at -80˚C . The levels of IFNγ, TNFα, IL-1β, IL-4, IL-6, IL-10, IL-33, CCL2, CCL3, CCL4, CCL5, CCL7, CCL20, CXCL1, CXCL2, CXCL5 and CXCL10 were measured Whole ear pinnae homogenates were diluted in 10-fold steps in LB medium and 10 μl of undiluted and diluted samples were pipetted onto sheep blood agar plates (Columbia Agar with sheep blood Plates; Oxoid, Cat. # PB0123A, Thermo Fisher Scientific, Waltham, Massachusetts). After incubation for 18 h at 37˚C, colony-forming units (CFU) were counted. The limit of detection was 40 CFU/ear. Whole ears homogenates underwent 3 cycles of freezing-thawing-sonicating to rupture cells and release the virus. Titres of infectious virus were then determined by plaque assay on BSC-1 cell monolayers. Titres of neutralizing antibodies were determined by a plaque reduction neutralization test, as described (62) . Briefly, after complement inactivation, two-fold serial dilutions of serum samples were prepared using 2.5% fetal bovine serum (FBS)/1% PenStrep/DMEM medium. The diluted serum samples, or reference samples (medium only), were mixed 1:1 with medium containing 3.2 × 10 2 PFU/ml of VACV WR and incubated for 1 h at 37˚C. Samples were then titrated by plaque assay and half maximal inhibitory concentrations (IC50) were calculated. Ear pinnae were collected at 8 and 12 d p.i. with VACV strain Western Reserve (WR), fixed in 4% PFA/PBS for 24 h at 4˚C and then stored in 70% ethanol at 4˚C until paraffin embedding. Transverse sections (6 μm) through the middle of the lesion were stained with haematoxylin and eosin (H&E) and were examined under an AxioObserver Z1 microscope with an Axio-Cam HRc camera (Carl Zeiss AG) using Axiovision software (Carl Zeiss AG). Smallpox vaccination increases skin bacteria that promote pathology and influence the host response (Epicentre, Illumina, Cat # MGP04100, Madison, Wisconsin) according to its instruction manual. Ear tissue collection and DNA extraction was performed in sterile conditions with singleuse instruments and consumables to avoid contamination with bacteria or bacterial DNA. Blank samples containing buffers with no tissue specimens were used as controls for contamination and were treated exactly as ear tissue samples. Blank controls were made for each batch corresponding to the day of tissue collection. DNA samples were diluted with nuclease free water (Ambion, Cat # AM9935, Austin, Texas) to normalise DNA concentrations to~90 ng/μl. The NEXTflex 16S V4 Amplicon-Seq Kit 2.0 (Bio Scientific, PerkinElmer, Waltham, Massachusetts) was used for the bacterial 16S library preparation according to the manufacturer's instructions with the exception that 150 ng of material was used for amplification with 11 and 22 PCR cycles for the first and second rounds of amplifications, respectively. Kapa Pure beads (KappaBiosystems, Cat # KK8002, Roche) were applied for purification and size selection of DNA with a volumetric ratio of 0.6X-0.8X. The final library was assessed by D1000 ScreenTape assay (Tapestation Agilent; Agilent Technologies, Santa Clara, California) for quality and fragment size, then quantified by Qubit dsDNA High Sensitivity Assay kit (Invitrogen, Thermo Fisher Scientific, Cat. # Q32854) and pooled to 10 nM. The final pool was quantified by qPCR with Kapa Library Quant Kit for Illumina Platforms (KapaBiosystems, Roche, Cat. # KK4824) on an AriaMX Real Time PCR System (Agilent Technologies). Next generation sequencing was performed by paired-end sequencing of the V4 region using MiSeq Reagent Kit version 3, 600-cycle format (Illumina). Library preparation and sequencing were completed by Cambridge Genomic Services. Data have been deposited to the European Nucleotide Archive. Processing and analysis of 16S sequence data is described in S1 Methods. Heatmap analysis. The heatmap was created using all samples with the R package Heatplus version 2.28.0. (S1 Methods). Taxon was selected if it was present in at least 5 samples with a minimum abundance of 1%. Five clusters were identified by specifying the "cuth" parameter (see S1 Methods). The heatmaps show 50 families from the family taxon datasets, 61 genera from the genus taxon datasets, and 72 species from the species taxon datasets. For the visualisation of microbial compositional differences between the different sample groups/timepoints we plotted the microbial variances using a multivariate method called Principal Component Analysis (PCA) for the family, genus, and species taxon level using the mixOmics R package version 6.7.1 [63] . PCA was conducted including all taxon with a minimum abundance of 0.1%. Statistical analysis was performed with SPSS v.25 (IBM, Armonk, New York) and GraphPad Prism v.8.3 (GraphPad Software, San Diego, California). Comparison between two groups of animals were done by Mann-Whitney U-test. The two-way repeated measures (RM) ANOVA test was used for the analysis of time series data. Correlations between parameters were assessed using Spearman correlation coefficient. P values of less than 0.05 were considered significant. Smallpox vaccination increases skin bacteria that promote pathology and influence the host response Cells were gated on their ability to scatter light. Doublets were excluded using a FSC-A versus FSC-H plot. Then, hemopoietic cells were gated as CD45 + Zombie dyecells. Further lymphoid subpopulations were classified as follows: NK cells: CD45 + CD3 -NK1.1 + ; TCRɣδ T cells: CD45 + CD3 + NK1.1 -TCRɣδ + ; CD4 T cells: CD45 + CD3 + NK1.1 -TCRɣδ -CD8 -CD4 + ; CD8 T cells: CD45 + CD3 + NK1.1 -TCRɣδ -CD4 -CD8 + . (TIFF) S12 Fig. Gating strategy for flow cytometry of splenic CD8 + and CD4 + T cells isolated one month after i.d. injection of ear pinnae with 10 4 PFU of VACV WR, or from mock-infected animals. Cells were gated on their ability to scatter light. Doublets were excluded using a FSC-A versus FSC-H plot. T cells were classified as CD45 + Zombie dye -CD3 + cells and then divided into CD8 + and CD4 + T subsets and with further gating of VACV-specific CD8 + T lymphocytes (CD45 + CD3 + CD4 -CD8 + Dextramer + ) (A). Phenotype of CD4 + and CD8 + T cells as well as Dextramer + CD8 + T cells were further examined using CD44 and CD62L markers to identify naïve (CD62L + CD44 -), central memory (CD62L + CD44 + ) and effector memory (CD62L -CD44 + ) subsets (B). (TIFF) S1 Smallpox and its eradication National surveillance in the United States Smallpox vaccines: targets of protective immunity Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity Modulating vaccinia virus immunomodulators to improve immunological memory Secondary bacterial infections associated with influenza pandemics Skin microbiota: a source of disease or defence? Skin microbiota-host interactions What is your diagnosis A case of facial cellulitis and necrotizing lymphadenitis due to cowpox virus infection Pathogenesis of fulminant monkeypox with bacterial sepsis after experimental infection with West African monkeypox virus in a cynomolgus monkey Control of adaptive immunity by the innate immune system Innate control of adaptive immunity: beyond the three-signal paradigm Targeting the innate immune response with improved vaccine adjuvants Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination Vaccine adjuvants: putting innate immunity to work A model for vaccinia virus pathogenesis and immunity based on intradermal injection of mouse ear pinnae A kinetic analysis of immune mediators in the lungs of mice infected with vaccinia virus and comparison with intradermal infection The neutrophil life cycle Increased attenuation but decreased immunogenicity by deletion of multiple vaccinia virus immunomodulators Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes Practical murine hematopathology: a comparative review and implications for research Compartmentalized control of skin immunity by resident commensals Cutaneous leishmaniasis induces a transmissible dysbiotic skin microbiota that promotes skin inflammation Mouse microbiota models: comparing germ-free mice and antibiotics treatment as tools for modifying gut bacteria Role of the microbiome in human development Gut microbiome and aging: physiological and mechanistic insights Role of the microbiota in immunity and inflammation The commensal microbiota and viral infection: a comprehensive review Dual role of commensal bacteria in viral infections Do the microbiota influence vaccines and protective immunity to pathogens? issues of sovereignty, federalism, and points-testing in the prokaryotic and eukaryotic spaces of the host-microbial superorganism Epithelial antimicrobial defence of the skin and intestine Dialogue between skin microbiota and immunity Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors Sebum free fatty acids enhance the innate immune defense of human sebocytes by upregulating beta-defensin-2 expression Anatomically restricted synergistic antiviral activities of innate and adaptive immune cells in the skin Inhibition of HeLa cell protein synthesis by the vaccinia virion Secondary bacterial infections complicating skin lesions Rapid cell division of Staphylococcus aureus during colonization of the human nose Staphylococcus aureus infection dynamics Microbiota is an essential element for mice to initiate a protective immunity against vaccinia virus Studies on the mechanisms of vaccina virus cytopathic effects. I. Inhibition of protein synthesis in infected cells is associated with virus-induced RNA synthesis Virus-induced cell motility Steroid hormone synthesis by a vaccinia enzyme: a new type of virus virulence factor Steroid hormone synthesis by vaccinia virus suppresses the inflammatory response to infection Multi-receptor detection of individual bacterial products by the innate immune system Mechanisms of bacterial pathogenicity The price of immunity Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure Clinical features of patients infected with 2019 novel coronavirus in Wuhan Longitudinal analyses reveal immunological misfiring in severe COVID-19 Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients Neutrophilic inflammation in the respiratory mucosa predisposes to RSV infection Microbiota regulates immune defense against respiratory tract influenza A virus infection The intestinal flora is required to support antibody responses to systemic immunization in infant and germ free mice Role of the microbiota in the modulation of vaccine immune responses The impact of the microbiome on immunity to vaccination in humans Modulation of immune responses to vaccination by the microbiota: implications and potential mechanisms TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination Gastrointestinal microbiome dysbiosis in infant mice alters peripheral CD8(+) T cell receptor signaling Enhanced efficacy of vaccination with vaccinia virus in old vs. young mice mixOmics: an R package for 'omics feature selection and multiple data integration We thank Gillian M. Fraser (Department of Pathology, University of Cambridge) and Stephen D. Bentley (Sanger Institute, Hinxton) for advice on bacteriological aspects of this study.